시장보고서
상품코드
1285918

세계의 신경보철 시장 규모, 점유율, 성장 분석 : 용도별, 기술별, 유형별 - 업계 예측(2023-2030년)

Global Neuroprosthetics Market Size, Share, Growth Analysis, By Application, By Technique, By Type - Industry Forecast 2023-2030

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 신경보철 시장 규모는 2021년에 215억 달러를 기록하고, 예측기간(2023-2030년) CAGR은 11.8%로 전망됩니다. 시장은 2022년 240억 3,000만 달러에서 2030년에는 541억 7,000만 달러로 확대될 것으로 예측됩니다.

세계의 신경보철 시장에 대해 조사했으며, 시장 개요와 함께 용도별, 기술별, 유형별, 지역별 동향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

주요 요약

상부 시장 분석

시장 규모

  • 시장 역학
  • 성장 촉진요인
  • 기회
  • 성장 억제요인
  • 과제

주요 시장 인사이트

  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장 생태계
  • IP 분석
  • 동향 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 주요 성공요인
  • 경쟁 정도

시장 역학과 전망

  • 시장 역학
  • 성장 촉진요인
  • 기회
  • 성장 억제요인
  • 과제
  • 규제 상황
  • Porters 분석

세계의 신경보철 시장, 용도별

  • 시장 개요
  • 운동 뉴런 장애
  • 생리적 질환
  • 인지 장애

세계의 신경보철 시장, 기술별

  • 시장 개요
  • 뇌 자극
  • 척수 자극
  • 미주 신경 자극
  • 기타

세계의 신경보철 시장, 유형별

  • 시장 개요
  • 출력용
  • 입력용

세계의 신경보철 시장, 지역별

  • 시장 개요
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

경쟁 상황

  • 주요 기업 개요
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cochlear Limited
  • Cyberonics, Inc.
  • Edwards Lifesciences Corporation
  • Envoy Medical Corporation
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NDI Medical LLC
  • NeuroPace, Inc.
  • Nevro Corp.
  • Otto Bock HealthCare GmbH
  • Retina Implant AG
  • Second Sight Medical Products, Inc.
  • Sonova Holding AG
  • St. Jude Medical, Inc.
  • Synapse Biomedical, Inc.
  • Terumo Corporation
  • Thoratec Corporation
  • Zimmer Biomet Holdings, Inc.
KSM 23.06.15

Neuroprosthetics Market size was valued at USD 21.5 billion in 2021 and is poised to grow from USD 24.03 billion in 2022 to USD 54.17 billion by 2030, growing at a CAGR of 11.8% in the forecast period (2023-2030).

The global neuroprosthetics market is experiencing steady growth due to advancements in medical technology. Neuroprosthetics are devices designed to restore or improve neural functions, benefiting individuals with disabilities or neurological disorders. The market is driven by increasing research and development activities, rising prevalence of neurological disorders, and growing demand for effective treatment options. Technological innovations and expanding healthcare infrastructure are expected to further propel market growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of Neuroprosthetics and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Global neuroprosthetics market is segmented on the basis of application, technique, type, and region. By application, the market is segmented into motor neuron disorders, physiological disorders, and cognitive disorders. By technique, the market is categorized into deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, and others. By type, the market is bifurcated into output neural prosthetics and input neural prosthetics. By region, the market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.

Driver

The global neuroprosthetics market is anticipated to experience significant growth during the forecast period, primarily driven by the high prevalence of neurological disorders and nerve-related injuries. These conditions are expected to be the key factors contributing to the market's expansion. To illustrate, neurological diseases alone have caused over 533,000 fatalities, with approximately 213,000 reported among males and around 320,000 among females. Neuroprosthetics devices offer numerous advantages for treating such diseases, making them an effective solution. Additionally, individuals suffering from hearing impairments can benefit from these devices, including cochlear implants and auditory brainstem implants (ABIs). Consequently, the growing demand for neuroprosthetics worldwide, which aids in the diagnosis and management of various disorders, is expected to drive the market's growth in the forthcoming years.

Restrain

The rising acceptance of alternative treatment approaches such as stem cell therapy presents significant prospects for addressing different neurological conditions. However, this trend is expected to impede the growth of the market in the foreseeable future. Stem cell therapy provides advantageous treatment options for neurological disorders like Parkinson's and Alzheimer's, offering cost-effective alternatives and simplified medication protocols that appeal to patients. As a result, this factor is likely to limit the worldwide expansion of the neuroprosthetics market during the projected period.

Trend

The increasing prevalence of hearing loss and advancements in technology have led to a rise in the popularity of neural prosthetics. These devices, which offer the ability to perceive sound to individuals who are deaf or hard of hearing, are becoming more appealing due to their user-friendly nature and affordable implementation costs. These factors present promising opportunities for the growth of neural prosthetics in the coming years. Additionally, our research indicates that cochlear implantation not only aids in diagnosing hearing loss but also shows potential as a therapeutic tool for rehabilitating tinnitus patients. As a result, the neuroprosthetics market is projected to experience significant expansion in the foreseeable future.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune
  • Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
  • Market Dynamics & Outlook
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Neuroprosthetics Market by Application

  • Market Overview
  • Motor Neuron Disorders
  • Physiological Disorders
  • Cognitive Disorders
  • Global Neuroprosthetics Market by Technique
  • Market Overview
  • Brain Stimulation
  • Spinal Cord Stimulation
  • Vagus Nerve Stimulation
  • others

Global Neuroprosthetics Market by Type

  • Market Overview
  • Output Neural Prosthetics
  • Input Neural Prosthetics
  • Global Neuroprosthetics Market Size by Region
  • Market Overview
  • North America
  • USA
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
  • By Development
  • By Company
  • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
  • Key Company Profiles
  • Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Cochlear Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Cyberonics, Inc. (LivaNova PLC)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Envoy Medical Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • NDI Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • NeuroPace, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Nevro Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Otto Bock HealthCare GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Retina Implant AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Second Sight Medical Products, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Sonova Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • St. Jude Medical, Inc. (Abbott Laboratories)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Synapse Biomedical, Inc. (Zynex, Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Thoratec Corporation (Abbott Laboratories)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Zimmer Biomet Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제